Clinical trial
An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex (EBS)
NCT03389308 is registered in ClinicalTrials.gov with Castle Creek Pharmaceuticals, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An International, Multicenter, Open-label, Long Term Extension Study Evaluating the Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex (EBS)
- Lead sponsor
- Castle Creek Pharmaceuticals, LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 1, 2017
- Completion date
- April 17, 2020
- Enrollment
- 51 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.